Research Article
TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus
Table 1
Demographic, anthropometric, and clinical characteristics and prescribed drugs of 80 patients with diabetes mellitus type 2.
| | Age (years) | 68 (38–78) | | Sex (male/female) | 32/48 | | Duration of diabetes (years) | 14 (1–37) | | Body mass index (kg/m2) | 26.1 (21.4–43.4) | | Mean blood pressure (mmHg) | 99.4 ± 8.6 | | Systolic blood pressure (mmHg) | 135.5 ± 13.2 | | Diastolic blood pressure (mmHg) | 81.4 ± 9.6 | | Hypertension | 53 (66.3) | | Smoking | 20 (25) | | Diabetic retinopathy | 31 (41.9) | | Cardiovascular disease | 33 (41.3) | | Diabetic neuropathy | 36 (59) | | Statins | 61 (76.3) | | Acetylosalicylic acid | 21 (26.3) | | Clopidogrel | 25 (31.3) | | ACEi/ARBs | 46 (57.5) | | Oral hypoglecemic agents | 55 (68.8) | | Insulin | 4 (5) | | Combination (oral hypoglecemic + insulin) | 21 (26.3) |
|
|
Values are expressed as means ± SD, median with range or number of patients (%) as appropriate.
|
